Monthly Archives: October 2017

//October

Diagnostic Scan – Ga68

The Gallium 68 scan, used with functional PET imaging, is a nuclear medicine scan that relies on the over-expression of somatostatin receptors to visualize tumours. NETs typically express several somatostatin receptor subtypes in [...]

By | 2018-05-07T18:28:11+00:00 October 4th, 2017|Treatment News|Comments Off on Diagnostic Scan – Ga68

Somatuline (lanreotide) Access in Manitoba & Alberta

As we advised previously, in July of this year the Manitoba government issued a bulletin http://www.gov.mb.ca/health/mdbif/…/bulletins/bulletin93.pdf that indicated a change in the listing for Somatuline (from 1 to 3 and no access [...]

By | 2018-05-07T18:28:11+00:00 October 2nd, 2017|Treatment News|Comments Off on Somatuline (lanreotide) Access in Manitoba & Alberta

Caprelsa (vandetanib) for Medullary Thyroid NETs

Caprelsa is indicated for the treatment of symptomatic or progressive medullary thyroid cancer (MTC) in adult patients with unresectable locally advanced or metastatic disease.   An application for this drug was [...]

By | 2018-05-07T18:28:11+00:00 October 2nd, 2017|Treatment News|Comments Off on Caprelsa (vandetanib) for Medullary Thyroid NETs